E. Garralda

机构：Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology

发表论文 7 篇 · 总被引 19 次 · h-index 3

代表论文

• 916O Preliminary phase I results of INCB161734, a novel oral KRAS G12D inhibitor, in patients with advanced or metastatic solid tumors (2025 · Annals of Oncology · 被引 10)
• 40O Phase I/Ib open-label study of an HER2-targeted T cell engager (TCE)‒SAR443216 in patients (pts) with advanced solid tumors: Intravenous (IV) dose-escalation results (2025 · ESMO Open · 被引 4)
• 1016eTiP A first-in-human phase I study of LY4066434, a potent and orally bioavailable pan-KRAS inhibitor, in KRAS-mutant solid tumors (Trial in Progress) (2025 · Annals of Oncology · 被引 3)
• 680TiP A phase I/IIa first-in-human clinical trial evaluating MDX2001, a multi-specific antibody in patients with advanced solid tumor malignancies (2024 · Annals of Oncology · 被引 2)
• 2904P Co-creation and iterative needs assessment with patients and healthcare providers in an International phase II TILs therapy trial (PRAGMATIL) (2025 · Annals of Oncology)
• 4O VHIO immune gene expression profiling (VIGex) panel, a tool to explore tumor immune microenvironment (2020 · Annals of Oncology)